Single-shot AAV-vectored vaccine against SARS-CoV-2 with fast and long-lasting immunity-Reference-Cited by-同舟云学术

Single-shot AAV-vectored vaccine against SARS-CoV-2 with fast and long-lasting immunity

Published:2022-07 Issue: Volume: Page:
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Wu Fuhua,Luo Shuang,Zhang Yongshun,Ou Yangsen,Wang Hairui,Guo Zhaofei,He Chunting,Bai Shuting,He Penghui,Jiang Min,Chen Xiaoyan,Du Guangsheng,Sun Xun^ORCID

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference63 articles.

1. WHO Coronavirus (COVID-19) Dashboard. Availabe from: https://covid19.who.int/.

2. SARS-CoV-2 vaccine protection and deaths among US veterans during 2021;Cohn;Science,2021

3. SARS-CoV-2 Variants: a synopsis of in vitro efficacy data of convalescent plasma, currently marketed vaccines, and monoclonal antibodies;Focosi;Viruses,2021

4. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity;Garcia-Beltran;Cell,2021

5. Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study;Israel;BMJ,2021

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronavirus spike protein-based vaccines. Vaccine delivery systems;Medicine in Drug Discovery;2024-09

2. rAAV expressing a COBRA-designed influenza hemagglutinin generates a protective and durable adaptive immune response with a single dose;Journal of Virology;2024-08-20

3. Virus-Mimetic Extracellular-Vesicle Vaccine Boosts Systemic and Mucosal Immunity via Immune Recruitment;ACS Nano;2024-07-16

4. Proof of concept in utilizing the peptidoglycan skeleton of pathogenic bacteria as antigen delivery platform for enhanced immune response;International Journal of Biological Macromolecules;2024-04

5. Co-delivery of oxaliplatin prodrug liposomes with Bacillus Calmette-Guérin for chemo-immunotherapy of orthotopic bladder cancer;Journal of Controlled Release;2024-01